DE602006014694D1 - Acyloxyalkylcarbamat-prodrugs von tranexansäure und anwendung - Google Patents
Acyloxyalkylcarbamat-prodrugs von tranexansäure und anwendungInfo
- Publication number
- DE602006014694D1 DE602006014694D1 DE602006014694T DE602006014694T DE602006014694D1 DE 602006014694 D1 DE602006014694 D1 DE 602006014694D1 DE 602006014694 T DE602006014694 T DE 602006014694T DE 602006014694 T DE602006014694 T DE 602006014694T DE 602006014694 D1 DE602006014694 D1 DE 602006014694D1
- Authority
- DE
- Germany
- Prior art keywords
- acid
- aminomethyl
- trans
- prodrugs
- acyloxyalkyl carbamate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/26—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Toxicology (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US69262505P | 2005-06-20 | 2005-06-20 | |
PCT/US2006/023873 WO2007002013A2 (en) | 2005-06-20 | 2006-06-20 | Acyloxyalkyl carbamate prodrugs of tranexamic acid, methods of synthesis and use |
Publications (1)
Publication Number | Publication Date |
---|---|
DE602006014694D1 true DE602006014694D1 (de) | 2010-07-15 |
Family
ID=37460256
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE602006014694T Active DE602006014694D1 (de) | 2005-06-20 | 2006-06-20 | Acyloxyalkylcarbamat-prodrugs von tranexansäure und anwendung |
Country Status (16)
Country | Link |
---|---|
US (4) | US7351740B2 (de) |
EP (1) | EP1919859B1 (de) |
JP (1) | JP4938771B2 (de) |
KR (1) | KR20080022203A (de) |
CN (1) | CN101253148B (de) |
AT (1) | ATE469880T1 (de) |
AU (1) | AU2006262386B2 (de) |
CA (1) | CA2612292C (de) |
DE (1) | DE602006014694D1 (de) |
ES (1) | ES2345784T3 (de) |
HK (1) | HK1117824A1 (de) |
IL (1) | IL188172A (de) |
NO (1) | NO20076508L (de) |
NZ (1) | NZ564468A (de) |
WO (1) | WO2007002013A2 (de) |
ZA (1) | ZA200800311B (de) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090214644A1 (en) * | 2003-07-31 | 2009-08-27 | Xanodyne Pharmaceuticals, Inc. | Tranexamic acid formulations with reduced adverse effects |
US20050025825A1 (en) * | 2003-07-31 | 2005-02-03 | Xanodyne Pharmacal, Inc. | Tranexamic acid formulations with reduced adverse effects |
US7947739B2 (en) | 2004-03-04 | 2011-05-24 | Ferring B.V. | Tranexamic acid formulations |
US20090215898A1 (en) * | 2004-03-04 | 2009-08-27 | Xanodyne Pharmaceuticals, Inc. | Tranexamic acid formulations |
US20050245614A1 (en) * | 2004-03-04 | 2005-11-03 | Xanodyne Pharmaceuticals, Inc. | Tranexamic acid formulations |
US20050244495A1 (en) | 2004-03-04 | 2005-11-03 | Xanodyne Pharmaceuticals, Inc. | Tranexamic acid formulations |
US8022106B2 (en) * | 2004-03-04 | 2011-09-20 | Ferring B.V. | Tranexamic acid formulations |
ES2345784T3 (es) | 2005-06-20 | 2010-10-01 | Xenoport, Inc. | Profarmacos de aciloxialquilcarbamato del acido tranexamico y uso de los mismos. |
CA2646123A1 (en) * | 2006-03-16 | 2007-09-27 | Vertex Pharmaceuticals Incorporated | Processes and intermediates for preparing steric compounds |
EP2217564A1 (de) * | 2007-09-07 | 2010-08-18 | XenoPort, Inc. | Prodrugs von acamprosat mit komplexer freisetzung durch pantosäureesterneopentylsulfonylestercyclisierung, zusammensetzungen davon und anwendungsverfahren |
US20090082464A1 (en) * | 2007-09-07 | 2009-03-26 | Bernd Jandeleit | Externally masked neopentyl sulfonyl ester cyclization release prodrugs of acamprosate, compositions thereof, and methods of use |
WO2010017504A1 (en) * | 2008-08-07 | 2010-02-11 | Xenoport, Inc. | Methods of synthesizing 1-(acyloxy)-alkyl carbamate prodrugs |
US7989641B2 (en) | 2008-08-07 | 2011-08-02 | Xenoport, Inc. | Methods of synthesizing N-hydroxysuccinimidyl carbonates |
US20100280117A1 (en) * | 2009-04-30 | 2010-11-04 | Xanodyne Pharmaceuticals, Inc. | Menorrhagia Instrument and Method for the Treatment of Menstrual Bleeding Disorders |
US20110060040A1 (en) * | 2009-09-04 | 2011-03-10 | Xenoport, Inc. | Uses of acyloxyalkyl carbamate prodrugs of tranexamic acid |
WO2011091164A1 (en) * | 2010-01-22 | 2011-07-28 | Xenoport, Inc. | Oral dosage forms having a high loading of a tranexamic acid prodrug |
US8597683B2 (en) | 2010-11-30 | 2013-12-03 | Watson Pharmaceuticals, Inc. | Modified release tranexamic acid formulation |
DE202012012713U1 (de) * | 2011-03-04 | 2014-01-23 | Arstat, Inc. | Intravaginale Arzneimittelabgabevorrichtung |
DE202011110392U1 (de) | 2011-04-12 | 2014-01-16 | Arstat, Inc. | Oral verabreichbare pharmazeutische Zusammensetzung zur behandlung von Menstruationsschmerzen, die von übermäßigem menstruellem Blutverlust begleitet sind |
FI125336B (fi) * | 2012-10-31 | 2015-08-31 | Kone Corp | Hissijärjestely |
EP3082866A4 (de) | 2013-12-16 | 2017-06-14 | The University Of British Columbia | Selbstbetriebene partikel zum antrieb durch strömende wässrige flüssigkeiten |
US20190083527A1 (en) * | 2017-09-15 | 2019-03-21 | Ampersand Biopharmaceuticals, Inc. | Method of administration and treatment |
WO2020074160A1 (en) | 2018-10-10 | 2020-04-16 | Curovir Ab | Condensed pyrimidine or pyridazine derivatives as antiviral agents |
JP2020090453A (ja) * | 2018-12-05 | 2020-06-11 | ポーラ化成工業株式会社 | 日焼け抑制用組成物 |
EP3984989A4 (de) * | 2020-08-13 | 2023-11-22 | Nanjing Heron Pharmaceutical Science and Technology Co., Ltd. | Ibuprofenester-prodrug, pharmazeutische zusammensetzung sowie herstellungsverfahren und verwendung |
JP2024507433A (ja) * | 2020-12-31 | 2024-02-20 | シノハブ ファーマシューティカルズ カンパニー リミテッド | プラスミン阻害剤、そのための調製方法及びその応用 |
EP4134362B1 (de) * | 2021-06-29 | 2024-02-28 | Nanjing Heron Pharmaceutical Science and Technology Co., Ltd. | Ibuprofenesterderivat und emulsionsformulierung davon |
Family Cites Families (73)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2996431A (en) * | 1953-12-16 | 1961-08-15 | Barry Richard Henry | Friable tablet and process for manufacturing same |
US3402240A (en) * | 1957-06-25 | 1968-09-17 | Pfizer & Co C | Medicinal tablet and process of making same |
US3139383A (en) * | 1961-06-26 | 1964-06-30 | Norton Co | Encapsulated time release pellets and method for encapsulating the same |
US3499925A (en) * | 1964-03-23 | 1970-03-10 | Daiichi Seiyaku Co | Process for the production of trans-4-aminomethylcyclohexane - 1 - carboxylic acid |
GB1364672A (en) * | 1971-06-09 | 1974-08-29 | Beecham Group Ltd | Penicillins |
US3962414A (en) * | 1972-04-27 | 1976-06-08 | Alza Corporation | Structured bioerodible drug delivery device |
US3845770A (en) * | 1972-06-05 | 1974-11-05 | Alza Corp | Osmatic dispensing device for releasing beneficial agent |
US3811444A (en) * | 1972-12-27 | 1974-05-21 | Alza Corp | Bioerodible ocular device |
US3916899A (en) * | 1973-04-25 | 1975-11-04 | Alza Corp | Osmotic dispensing device with maximum and minimum sizes for the passageway |
DE2336218C3 (de) * | 1973-07-17 | 1985-11-14 | Byk Gulden Lomberg Chemische Fabrik Gmbh, 7750 Konstanz | Orale Arzneiform |
US4048222A (en) * | 1974-03-04 | 1977-09-13 | Kureha Kagaku Kogyo Kabushiki Kaisha | Process for preparing trans-4-aminomethyl-cyclohexane-1-carboxylic acid |
US3992518A (en) * | 1974-10-24 | 1976-11-16 | G. D. Searle & Co. | Method for making a microsealed delivery device |
GB1478759A (en) * | 1974-11-18 | 1977-07-06 | Alza Corp | Process for forming outlet passageways in pills using a laser |
US4093709A (en) * | 1975-01-28 | 1978-06-06 | Alza Corporation | Drug delivery devices manufactured from poly(orthoesters) and poly(orthocarbonates) |
JPS51138651A (en) * | 1975-05-27 | 1976-11-30 | Kureha Chem Ind Co Ltd | Process for pr eparing trans-4-aminomethyo-cyclohexane |
US4055580A (en) * | 1975-08-22 | 1977-10-25 | Rorer Italiana S.P.A. | Derivatives of aminomethylcyclohexanecarboxylic acid |
US4063064A (en) * | 1976-02-23 | 1977-12-13 | Coherent Radiation | Apparatus for tracking moving workpiece by a laser beam |
US4079038A (en) * | 1976-03-05 | 1978-03-14 | Alza Corporation | Poly(carbonates) |
US4066747A (en) * | 1976-04-08 | 1978-01-03 | Alza Corporation | Polymeric orthoesters housing beneficial drug for controlled release therefrom |
US4070347A (en) * | 1976-08-16 | 1978-01-24 | Alza Corporation | Poly(orthoester) co- and homopolymers and poly(orthocarbonate) co- and homopolymers having carbonyloxy functionality |
US4285987A (en) * | 1978-10-23 | 1981-08-25 | Alza Corporation | Process for manufacturing device with dispersion zone |
US4200098A (en) * | 1978-10-23 | 1980-04-29 | Alza Corporation | Osmotic system with distribution zone for dispensing beneficial agent |
US4290905A (en) * | 1979-12-26 | 1981-09-22 | Kabushiki Kaisha Suwa Seikosha | Ester compound |
EP0079872B1 (de) * | 1981-11-17 | 1985-03-20 | KabiVitrum AB | Verbindungen mit antifibrinolytischer Wirksamkeit |
US4434153A (en) * | 1982-03-22 | 1984-02-28 | Alza Corporation | Drug delivery system comprising a reservoir containing a plurality of tiny pills |
US4421736A (en) * | 1982-05-20 | 1983-12-20 | Merrel Dow Pharmaceuticals Inc. | Sustained release diethylpropion compositions |
US4426391A (en) * | 1982-09-15 | 1984-01-17 | Merck & Co., Inc. | [(Alkoxycarbonyl)oxy]alkyl esters of methyldopa |
IL67445A (en) | 1982-12-09 | 1985-11-29 | Teva Pharma | Ethoxycarbonyloxy ethyl esters of non-steroidal anti-inflammatory carboxylic acids |
US4721613A (en) * | 1982-12-13 | 1988-01-26 | Alza Corporation | Delivery system comprising means for shielding a multiplicity of reservoirs in selected environment of use |
US4760057A (en) * | 1983-06-23 | 1988-07-26 | Merck & Co., Inc. | (Acyloxyalkoxy)carbonyl derivatives as bioreversible prodrug moieties for primary and secondary amine functions in drugs |
US4916230A (en) * | 1984-07-02 | 1990-04-10 | Merck & Co., Inc. | Process for preparing novel N-(acyloxy-alkoxy)carbonyl derivatives useful as bioreversible prodrug moieties for primary and secondary amine functions in drugs |
US4820523A (en) * | 1986-04-15 | 1989-04-11 | Warner-Lambert Company | Pharmaceutical composition |
US4752470A (en) * | 1986-11-24 | 1988-06-21 | Mehta Atul M | Controlled release indomethacin |
US4851423A (en) * | 1986-12-10 | 1989-07-25 | Schering Corporation | Pharmaceutically active compounds |
US4816263A (en) * | 1987-10-02 | 1989-03-28 | Alza Corporation | Dosage form for treating cardiovascular diseases comprising isradipine |
US4853229A (en) * | 1987-10-26 | 1989-08-01 | Alza Corporation | Method for adminstering tiny pills |
EP0416689B1 (de) | 1989-09-06 | 1995-11-29 | Merck & Co. Inc. | Acyloxymethylester der Bisphonsäuren als Knochenresorptions-Inhibitoren |
GB9001405D0 (en) * | 1990-01-22 | 1990-03-21 | Leo Pharm Prod Ltd | New intermediates,their production and use |
US5698155A (en) * | 1991-05-31 | 1997-12-16 | Gs Technologies, Inc. | Method for the manufacture of pharmaceutical cellulose capsules |
US5229135A (en) * | 1991-11-22 | 1993-07-20 | Prographarm Laboratories | Sustained release diltiazem formulation |
DE69316681T2 (de) * | 1992-08-27 | 1998-05-14 | Shiseido Co Ltd | Äusserliche, auf der Haut anzuwendende Depigmentierungsmittel enthaltende Zusammensetzung |
SE9300013L (sv) * | 1992-12-30 | 1994-07-01 | Kabi Pharmacia Ab | Nytt förfarande och mellanprodukter för framställning av pro- läkemedel |
JPH07165555A (ja) * | 1993-12-09 | 1995-06-27 | Shiseido Co Ltd | 皮膚外用剤 |
US5466811A (en) * | 1994-07-18 | 1995-11-14 | Merck & Co., Inc. | Dioxolenylmethyl carbamates pro moieties for amine drugs |
US5684018A (en) * | 1994-12-13 | 1997-11-04 | Merck & Co., Inc. | Acyloxyisopropyl carbamates as prodrugs for amine drugs |
DK0797987T3 (da) | 1994-12-19 | 2004-02-16 | Daiichi Seiyaku Co | Granulært præparat med langvarig frigivelse og fremgangsmåde til fremstilling deraf |
JP3483988B2 (ja) * | 1995-06-01 | 2004-01-06 | 株式会社資生堂 | 皮膚外用剤 |
JP3814881B2 (ja) * | 1996-08-07 | 2006-08-30 | 味の素株式会社 | シクロヘキシルアミノ酸類の製造方法 |
US6375987B1 (en) * | 1996-10-01 | 2002-04-23 | Gattefossé, S.A. | Process for the manufacture of pharmaceutical composition with modified release of active principle comprising the matrix |
FR2779651B1 (fr) * | 1998-06-16 | 2001-04-20 | Gattefosse Ets Sa | Procede pour la fabrication de comprimes a liberation prolongee de principe(s) actif(s) presentant une cinetique de dissolution d'ordre zero |
US6171615B1 (en) * | 1998-07-06 | 2001-01-09 | Gattefoss{acute over (e)} | Sustained release theophylline formulations, excipient systems and methods of production |
WO2001005813A1 (en) | 1999-07-15 | 2001-01-25 | Eli Lilly And Company | Pseudomycin prodrugs |
US6627223B2 (en) * | 2000-02-11 | 2003-09-30 | Eurand Pharmaceuticals Ltd. | Timed pulsatile drug delivery systems |
US6818787B2 (en) * | 2001-06-11 | 2004-11-16 | Xenoport, Inc. | Prodrugs of GABA analogs, compositions and uses thereof |
EP2085087A1 (de) * | 2001-06-11 | 2009-08-05 | Xenoport, Inc. | Prodrugs aus GABA-Analoga, Zusammensetzungen und ihre Verwendungen |
US7186855B2 (en) * | 2001-06-11 | 2007-03-06 | Xenoport, Inc. | Prodrugs of GABA analogs, compositions and uses thereof |
US7232924B2 (en) * | 2001-06-11 | 2007-06-19 | Xenoport, Inc. | Methods for synthesis of acyloxyalkyl derivatives of GABA analogs |
WO2003077902A1 (en) * | 2002-02-19 | 2003-09-25 | Xenoport, Inc. | Methods for synthesis of prodrugs from 1-acyl-alkyl derivatives and compositions thereof |
ITMI20030882A1 (it) * | 2003-04-30 | 2004-11-01 | Eni Spa | Metodo per inibire l'acidificazione biologica di acque in contatto con materiali contenenti zolfo |
WO2005010011A2 (en) * | 2003-07-15 | 2005-02-03 | Xenoport, Inc. | Methods of synthesis of acyloxyalkyl compounds |
US7860074B2 (en) * | 2003-07-31 | 2010-12-28 | Motorola, Inc. | Method and apparatus for allocating communication resources |
US7109239B2 (en) * | 2003-08-20 | 2006-09-19 | Xenoport, Inc. | Acyloxyalkyl carbamate prodrugs, methods of synthesis and use |
PL1677767T3 (pl) * | 2003-10-14 | 2011-12-30 | Xenoport Inc | Krystaliczna postać analogu kwasu gamma-aminomasłowego |
EP1716115B1 (de) | 2003-12-30 | 2013-02-27 | XenoPort, Inc. | Synthese von acyloxyalkylcarbamat-prodrugs und zwischenprodukten davon |
US20050244495A1 (en) * | 2004-03-04 | 2005-11-03 | Xanodyne Pharmaceuticals, Inc. | Tranexamic acid formulations |
CN102429882B (zh) * | 2004-11-04 | 2015-03-25 | 什诺波特有限公司 | 加巴喷丁前体药物持续释放口服剂型 |
ES2345784T3 (es) * | 2005-06-20 | 2010-10-01 | Xenoport, Inc. | Profarmacos de aciloxialquilcarbamato del acido tranexamico y uso de los mismos. |
US7332924B2 (en) * | 2005-11-15 | 2008-02-19 | Agere Systems, Inc. | Embedded test circuitry and a method for testing a semiconductor device for breakdown, wearout or failure |
US7770070B2 (en) * | 2007-06-21 | 2010-08-03 | Xerox Corporation | Test automation via RFID technology |
WO2010017504A1 (en) | 2008-08-07 | 2010-02-11 | Xenoport, Inc. | Methods of synthesizing 1-(acyloxy)-alkyl carbamate prodrugs |
US7989641B2 (en) | 2008-08-07 | 2011-08-02 | Xenoport, Inc. | Methods of synthesizing N-hydroxysuccinimidyl carbonates |
CN102186804A (zh) * | 2008-10-20 | 2011-09-14 | 克塞诺波特公司 | 合成左旋多巴酯前药的方法 |
KR20110126747A (ko) * | 2009-03-06 | 2011-11-23 | 제노포트 인코포레이티드 | 고용량의 가바펜틴 프로드러그를 갖는 경구 투여 제형 |
-
2006
- 2006-06-20 ES ES06785134T patent/ES2345784T3/es active Active
- 2006-06-20 KR KR1020087001522A patent/KR20080022203A/ko active IP Right Grant
- 2006-06-20 CA CA2612292A patent/CA2612292C/en not_active Expired - Fee Related
- 2006-06-20 AU AU2006262386A patent/AU2006262386B2/en not_active Ceased
- 2006-06-20 EP EP06785134A patent/EP1919859B1/de not_active Not-in-force
- 2006-06-20 US US11/455,855 patent/US7351740B2/en not_active Expired - Fee Related
- 2006-06-20 CN CN200680030032XA patent/CN101253148B/zh not_active Expired - Fee Related
- 2006-06-20 ZA ZA200800311A patent/ZA200800311B/xx unknown
- 2006-06-20 AT AT06785134T patent/ATE469880T1/de not_active IP Right Cessation
- 2006-06-20 WO PCT/US2006/023873 patent/WO2007002013A2/en active Application Filing
- 2006-06-20 JP JP2008517221A patent/JP4938771B2/ja not_active Expired - Fee Related
- 2006-06-20 NZ NZ564468A patent/NZ564468A/en not_active IP Right Cessation
- 2006-06-20 DE DE602006014694T patent/DE602006014694D1/de active Active
-
2007
- 2007-10-12 US US11/871,906 patent/US7592369B2/en not_active Expired - Fee Related
- 2007-12-17 IL IL188172A patent/IL188172A/en not_active IP Right Cessation
- 2007-12-19 NO NO20076508A patent/NO20076508L/no not_active Application Discontinuation
-
2008
- 2008-10-08 HK HK08111151.4A patent/HK1117824A1/xx not_active IP Right Cessation
-
2009
- 2009-08-14 US US12/541,861 patent/US7777070B2/en not_active Expired - Fee Related
-
2010
- 2010-07-13 US US12/835,663 patent/US8372881B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US7777070B2 (en) | 2010-08-17 |
US7351740B2 (en) | 2008-04-01 |
US7592369B2 (en) | 2009-09-22 |
IL188172A0 (en) | 2008-03-20 |
CN101253148B (zh) | 2013-01-02 |
HK1117824A1 (en) | 2009-01-23 |
WO2007002013A3 (en) | 2007-03-22 |
US20080153898A1 (en) | 2008-06-26 |
AU2006262386B2 (en) | 2012-02-02 |
CA2612292C (en) | 2013-09-03 |
CN101253148A (zh) | 2008-08-27 |
US8372881B2 (en) | 2013-02-12 |
JP4938771B2 (ja) | 2012-05-23 |
EP1919859B1 (de) | 2010-06-02 |
AU2006262386A1 (en) | 2007-01-04 |
ZA200800311B (en) | 2009-04-29 |
NZ564468A (en) | 2011-05-27 |
IL188172A (en) | 2013-02-28 |
WO2007002013A2 (en) | 2007-01-04 |
EP1919859A2 (de) | 2008-05-14 |
NO20076508L (no) | 2008-03-17 |
CA2612292A1 (en) | 2007-01-04 |
ES2345784T3 (es) | 2010-10-01 |
ATE469880T1 (de) | 2010-06-15 |
JP2008546717A (ja) | 2008-12-25 |
US20110009483A1 (en) | 2011-01-13 |
US20100036148A1 (en) | 2010-02-11 |
US20070027210A1 (en) | 2007-02-01 |
KR20080022203A (ko) | 2008-03-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE602006014694D1 (de) | Acyloxyalkylcarbamat-prodrugs von tranexansäure und anwendung | |
WO2005019163A3 (en) | Acyloxyalkyl carbamate prodrugs, methods of synthesis and use | |
ATE511392T1 (de) | Verzögert freigesetzte orale dosierungsformen eines prodrugs von r-baclofen und behandlungsverfahren damit | |
DK1819227T3 (da) | Farmaceutisk formulering af decitabin | |
EA200800783A1 (ru) | Композиция тразодона для введения один раз в день | |
MX2010001242A (es) | Profarmacos de canabidiol, composiciones que comprenden profarmacos de canabidiol y metodos para utilizar los mismos. | |
EA201190139A1 (ru) | Производные тиенопиримидиндиона в качестве модуляторов trpa1 | |
EA200802020A1 (ru) | Тетрагидропиримидоазепины и их применение в качестве модуляторов trpv 1 | |
MX2010005931A (es) | Profarmacos de tetrahidrocanabinol, composiciones que comprenden profarmacos de tetrahidrocanabinol y metodos para utilizar los mismos. | |
EA200901032A1 (ru) | Соединения и композиции в качестве модуляторов активности gpr119 | |
CY1108932T1 (el) | Ενωσεις 4-(ετεροκυκλυλ)-βενζολοσουλφοξιμινης για την θεραπευτικη αγωγη φλεγμονωδων ασθενειων | |
ATE410408T1 (de) | Von aminosäuren abgeleitete prodrugs von propofolzusammensetzungen und anwendungen davon | |
ECSP045029A (es) | Composiciones de valdecoxib de disgregación intraoral | |
EA201100921A1 (ru) | Соединения, фармацевтические композиции и способы их применения при лечении нарушений обмена веществ | |
PT1853232E (pt) | Forma cristalina estável de mesilato de bifeprunox, suas formas de dosagem e métodos para a sua utilização | |
WO2006050472A3 (en) | Acyloxyalkyl carbamate prodrugs of 3-aminopropylphosphonous and -phosphinic acids | |
WO2006050471A3 (en) | Acyloxyalkyl carbamate prodrugs of sulfinic acids, methods of synthesis, and use | |
DOP2006000287A (es) | Derivados de piperidina | |
CY1109975T1 (el) | Παρα-αλκυλ-υποκατεστημενα αμιδια ν-(4-υδροξυ-3-μεθοξυ-βενζυλο) κιναμμωμικου οξεος και η χρησιμοποιηση τους για την παρασκευη φαρμακων | |
CY1109666T1 (el) | Μεθοδος θεραπειας διαταραχων ξηροφθαλμιας και ραγοειδιτιδας | |
WO2008013860A3 (en) | Acyloxyalkyl carbamate prodrugs of alpha-amino acids, methods of synthesis and use | |
ATE495159T1 (de) | Diaminocyclohexan- und diaminocyclopentanderivate | |
DE602004010314D1 (de) | Behandlung von neurodegenerativen erkrankungen durch verwendung von degs-inhibitoren | |
EA200501865A1 (ru) | Аналоги тиовольфраматов и их применение | |
UY29640A1 (es) | Amidas sustituidas con heteroarilo que comprenden un grupo enlazador saturado, y su uso como agentes farmacéuticos. |